We found that CDC42 was highly enriched in high-grade glioma patients (Figures 3F, J), IDH wild-type glioma patients (Figures 3C, G), non-methylated glioma patients (Figures 3D, H), and non-codeletion glioma patients (Figures 3E, I) in TCGA and CGGA databases. Here, CDC42 is linked to central nervous system cancer.